Yıl: 2022 Cilt: 12 Sayı: 1 Sayfa Aralığı: 29 - 36 Metin Dili: İngilizce DOI: 10.5152/entupdates.2022.22162 İndeks Tarihi: 20-09-2022

A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis

Öz:
Objectives: Thirteen cases of laryngeal chondroradionecrosis unresponsive to conservative treatment and treated with laryngectomy were presented with an analysis of possible risk factors. Methods: Retrospective analysis of 13 patients operated on for chondroradionecrosis was made. Characteristics of the primary tumor, chondroradionecrosis grade, number of biopsies needed to rule out recurrence, and laryngectomy indications were analyzed. The possible predisposing factors such as alcohol and tobacco use and other major chronic diseases were investigated. Results: All of the patients had a history of smoking. The most common comorbidity was hypertension (46.2%), followed by chronic obstructive pulmonary disease (23.1%). The onset of symptoms was documented within the 10 months following the radiation therapy in 12 of the patients (93.3%) and 12 years after the primary radiation therapy in 1 patient. As the most common symptom, fetor oris was observed in all of the patients, followed by dysphagia (69.2%), hoarseness (61.5%), pain (53.8%), dyspnea (46.2%), and necrotic fistula formation in the anterior neck (15.4%) consecutively. Tumor suspicion (84.6%) was the most common indication for laryngectomy followed by chronic aspiration or feeding disorder (61.5%). Twelve patients were treated with total and 1 with supraglottic laryngectomy. Pectoralis major muscle flap was used in all of the patients for pharyngeal reconstruction or protection against salivary fistula. Conclusion: Diagnosis of chondroradionecrosis is challenging, and tumor recurrence should always be kept in mind. Patients must be informed about the possibility of chondroradionecrosis complications including laryngectomy. Introduction: Chondroradionecrosis is a rare and the most severe complication of radiation therapy for laryngeal carcinoma.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30. [CrossRef]
  • 2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [CrossRef]
  • 3. Overgaard J, Mohanti BK, Begum N, et al. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial. Lancet Oncol. 2010;11(6):553-560. [CrossRef]
  • 4. Al-Mamgani A, van Rooij PH, Woutersen DP, et al. Radiotherapy for T1-2N0 glottic cancer: a multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients. Clin Otolaryngol. 2013;38(4):306-312. [CrossRef]
  • 5. Chandler JR. Radiation fibrosis and necrosis of the larynx. Ann Otol Rhinol Laryngol. 1979;88(4 Pt 1):509-514. [CrossRef]
  • 6. Roh JL. Chondroradionecrosis of the larynx: diagnostic and therapeutic measures for saving the organ from radiotherapy sequelae. Clin Exp Otorhinolaryngol. 2009;2(3):115-119. [CrossRef]
  • 7. Farneti D, Fabbri C, Prencipe SR. Chondroradionecrosis of the larynx. Curr Opin Otolaryngol Head Neck Surg. 2019;27(6):463-466. [CrossRef]
  • 8. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006;24(17):2618-2623. [CrossRef]
  • 9. Keene M, Harwood AR, Bryce DP, van Nostrand AW. Histopathological study of radionecrosis in laryngeal carcinoma. Laryngoscope. 1982;92(2):173-180. [CrossRef]
  • 10. Rugg T, Saunders MI, Dische S. Smoking and mucosal reactions to radiotherapy. Br J Radiol. 1990;63(751):554-556. [CrossRef]
  • 11. Des Rochers C, Dische S, Saunders MI. The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clin Oncol (R Coll Radiol). 1992;4(4):214-216. [CrossRef]
  • 12. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26(21):3582-3589. [CrossRef]
  • 13. Miyaguchi M, Takashima H, Kubo T. Laryngeal necrosis after combined chemotherapy and radiation therapy. J Laryngol Otol. 1997;111(8):763-765. [CrossRef]
  • 14. Phillips TL. Effects of chemotherapy and irradiation on normal tissues. Front Radiat Ther Oncol. 1992;26:45-54. [CrossRef]
  • 15. Lederman M. Radiation therapy in cancer of the larynx. JAMA. 1972;221(11):1253-1254.
  • 16. Fitzgerald PJ, Koch RJ. Delayed radionecrosis of the larynx. Am J Otolaryngol. 1999;20(4):245-249. [CrossRef]
  • 17. Gessert TG, Britt CJ, Maas AMW, Wieland AM, Harari PM, Hartig GK. Chondroradionecrosis of the larynx: 24-year University of Wisconsin experience. Head Neck. 2017;39(6):1189-1194. [CrossRef]
  • 18. Hermans R, Pameijer FA, Mancuso AA, Parsons JT, Mendenhall WM. CT findings in chondroradionecrosis of the larynx. AJNR Am J Neuroradiol. 1998;19(4):711-718.
  • 19. Gillespie J. Imaging of the post-treatment neck. Clin Radiol. 2020;75(10):794.e7-794.e17. [CrossRef]
  • 20. Rowley H, Walsh M, McShane D, Fraser I, O’Dwyer TP. Chondroradionecrosis of the larynx: still a diagnostic dilemma. J Laryngol Otol. 1995;109(3):218-220. [CrossRef]
  • 21. Greven KM, Williams DW 3rd, Keyes JW Jr, McGuirt WF, Watson NE Jr, Case LD. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am. 1997;3(6):353-357.
  • 22. Allen CT, Lee CJ, Merati AL. Clinical assessment and treatment of the dysfunctional larynx after radiation. Otolaryngol Head Neck Surg. 2013;149(6):830-839. [CrossRef]
  • 23. Hart GB, Mainous EG. The treatment of radiation necrosis with hyperbaric oxygen (OHP). Cancer. 1976;37(6):2580-2585. [CrossRef]
  • 24. Feldmeier JJ, Heimbach RD, Davolt DA, Brakora MJ. Hyperbaric oxygen as an adjunctive treatment for severe laryngeal necrosis: a report of nine consecutive cases. Undersea Hyperb Med. 1993;20(4):329-335.
  • 25. London SD, Park SS, Gampper TJ, Hoard MA. Hyperbaric oxygen for the management of radionecrosis of bone and cartilage. Laryngoscope. 1998;108(9):1291-1296. [CrossRef]
  • 26. Narozny W, Sicko Z, Kot J, Stankiewicz C, Przewozny T, Kuczkowski J. Hyperbaric oxygen therapy in the treatment of complications of irradiation in head and neck area. Undersea Hyperb Med. 2005;32(2):103-110.
  • 27. Feldmeier J, Carl U, Hartmann K, Sminia P. Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb Med. 2003;30(1):1-18.
  • 28. Feldmeier JJ, Heimbach RD, Davolt DA, Brakora MJ, Sheffield PJ, Porter AT. Does hyperbaric oxygen have a cancer-causing or -promoting effect? A review of the pertinent literature. Undersea Hyperb Med. 1994;21(4):467-475.
  • 29. Guimarães AV, Aires FT, Dedivitis RA, et al. Efficacy of pectoralis major muscle flap for pharyngocutaneous fistula prevention in salvage total laryngectomy: A systematic review. Head Neck. 2016;38(suppl 1):E2317-E2321. [CrossRef]
APA Başaran B, Çaytemel B, Sen C, ASLAN İ, Doruk C, ÜNSALER S (2022). A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. , 29 - 36. 10.5152/entupdates.2022.22162
Chicago Başaran Bora,Çaytemel Berkay,Sen Comert,ASLAN İsmet,Doruk Can,ÜNSALER SELİN A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. (2022): 29 - 36. 10.5152/entupdates.2022.22162
MLA Başaran Bora,Çaytemel Berkay,Sen Comert,ASLAN İsmet,Doruk Can,ÜNSALER SELİN A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. , 2022, ss.29 - 36. 10.5152/entupdates.2022.22162
AMA Başaran B,Çaytemel B,Sen C,ASLAN İ,Doruk C,ÜNSALER S A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. . 2022; 29 - 36. 10.5152/entupdates.2022.22162
Vancouver Başaran B,Çaytemel B,Sen C,ASLAN İ,Doruk C,ÜNSALER S A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. . 2022; 29 - 36. 10.5152/entupdates.2022.22162
IEEE Başaran B,Çaytemel B,Sen C,ASLAN İ,Doruk C,ÜNSALER S "A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis." , ss.29 - 36, 2022. 10.5152/entupdates.2022.22162
ISNAD Başaran, Bora vd. "A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis". (2022), 29-36. https://doi.org/10.5152/entupdates.2022.22162
APA Başaran B, Çaytemel B, Sen C, ASLAN İ, Doruk C, ÜNSALER S (2022). A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. ENT Updates, 12(1), 29 - 36. 10.5152/entupdates.2022.22162
Chicago Başaran Bora,Çaytemel Berkay,Sen Comert,ASLAN İsmet,Doruk Can,ÜNSALER SELİN A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. ENT Updates 12, no.1 (2022): 29 - 36. 10.5152/entupdates.2022.22162
MLA Başaran Bora,Çaytemel Berkay,Sen Comert,ASLAN İsmet,Doruk Can,ÜNSALER SELİN A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. ENT Updates, vol.12, no.1, 2022, ss.29 - 36. 10.5152/entupdates.2022.22162
AMA Başaran B,Çaytemel B,Sen C,ASLAN İ,Doruk C,ÜNSALER S A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. ENT Updates. 2022; 12(1): 29 - 36. 10.5152/entupdates.2022.22162
Vancouver Başaran B,Çaytemel B,Sen C,ASLAN İ,Doruk C,ÜNSALER S A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis. ENT Updates. 2022; 12(1): 29 - 36. 10.5152/entupdates.2022.22162
IEEE Başaran B,Çaytemel B,Sen C,ASLAN İ,Doruk C,ÜNSALER S "A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis." ENT Updates, 12, ss.29 - 36, 2022. 10.5152/entupdates.2022.22162
ISNAD Başaran, Bora vd. "A Diagnostic Challenge: Risk Factors and Surgical Treatment of Laryngeal Chondroradionecrosis". ENT Updates 12/1 (2022), 29-36. https://doi.org/10.5152/entupdates.2022.22162